Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease

Neuroscience Letters

Volumn 336, Issue 2, 2003, Pages 105-108

  Abe, Takashi ^a   Isobe, Chiaki ^a   Murata, Takahiko ^a   Sato, Chigumi ^a   Tohgi, Hideo ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

8 hydroxyguanosine; Cerebrospinal fluid; Oxidative stress; Parkinson's disease; RNA

Indexed keywords

8 HYDROXYGUANOSINE; BIOLOGICAL MARKER; GUANOSINE DERIVATIVE; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM;

BIOLOGICAL MARKERS; FEMALE; GUANOSINE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; RNA; SENSITIVITY AND SPECIFICITY; STATISTICS;

EID: 0037448323     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01259-4     Document Type: Article

References (27)

1. Alam Z.L., Daniel S.E., Lee A.J., Marson D.C., Jenner P., Halliwell B. A generalised increase in protein carbonyol in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69:1997;1323-1329.
2. Alam Z.I., Jenner A., Dniel S.E., Lee A.J., Cairns N., Marsden C.D., Jenner P., Halliwell B. Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69:1997;1196-1203.
3. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative disease. Ann. Neurol. 38:1995;357-366.
4. Dani S.U. Molecular turnover and aging. Dani S.U., Hori A., Walter G.F. Principles of Neural Aging. 1997;83-101 Elsevier, Amsterdam.
5. Dexter D.T., Sian J., Rose S., Hindmarsh J.G., Mann V.M., Copper J.M., Wells F.R., Daniel S.E., Lees A.J., Schapira A.H.V., Jenner P., Marsden C.D. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35:1994;38-44.
6. Dexter D.T., Well F.R., Lees A.J., Agid Y., Jenner P., Marsden C.D. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 89:1989;1830-1936.
7. Fiala E.S., Conaway C.C., Mathis J.E. Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane. Cancer Res. 49:1989;5518-5522.
8. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222:1999;236-245.
9. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11:1956;298-300.
10. Hirsh E.S. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease. Ann. Neurol. 32:1992;S88-S93.
11. Koller W.C. How accurately can Parkison's disease be diagnosed? Neurology. 42:1992;6-16.
12. Lin C-L.G., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J.D. Aberrant RNA processing in a neurodegerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron. 20:1998;589-602.
13. Mitilineon C., Han S.K., Cohen G. Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J. Neurochem. 61:1993;1470-1478.
14. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;759-767.
15. Nunomura A., Perry G., Pappolla M.A., Friedland R., Hirai K., Chiba S., Smith M.A. Neuronal oxidative stress proceeds amyloid-β deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 59:2000;1011-1017.
16. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidations is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19:1999;1959-1964.
17. Nunomura A., Perry G., Zhang J., Montine T.J., Takeda A., Chiba S., Smith M.A. RNA oxidation in Alzheimer and Parkinson diseases. J. Anti-Aging Med. 2:1999;227-230.
18. Perry T.L., Godin D.V., Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:1982;305-310.
19. Rhee Y., Valentine M.R., Termini J. Oxidative base damage in RNA detected by reverse transcriptase. Nucleic Acids Res. 23:1995;3275-3282.
20. Sayre L.M., Perry G., Smith M.A. In situ methods for detection and localization of markers of oxidative stress: Application in neurodegenerative disorders. Methods Enzymol. 309:1999;133-152.
21. Shigenaga M.K., Gimeno C.J., Ames B.N. Urinary 8-hydroxy-27′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. USA. 86:1989;9697-9701.
22. Taddei F., Hayakawa H., Bouton M.F., Cirinesi A., Matic I., Sekiguchi M., Radman M. Counteraction by MutT protein of transcriptional errors caused by oxidative damage. Science. 278:1997;128-130.
23. van Leeuwen F.W., de Kleijn D.P.V., van den Hurk H.H., Neubauer A., Sonnemans M.A., Slluijs J.A., Koycu S., Ramdjielal R.D., Salehi A., Martens G.J., Grosveld F.G., Peter J., Burbach H., Hol E.M. Frameshift mutants of β amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science. 279:1998;242-247.
24. Wamer W.G., Wei R.R. In vitro photooxidation of nucleic acids by ultraviolet A radiation. Photochem. Photobiol. 6:1997;560-563.
25. Wamer W.G., Yin J.J., Wei R.R. Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radical Biol. Med. 23:1997;851-858.
26. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadman E.R., Mizno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson's disease. Proc. Natl. Acad. Sci. USA. 93:1996;2696-2701.
27. Zhang J., Perry G., Smith M.A., Robertson D., Olson S.J., Graham D.J., Montine T.J. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154:1999;1423-1429.